Stryker Corp
(BSP:S1YK34)
R$
109.25
0 (0%)
Market Cap: 832.96 Bil
Enterprise Value: 899.10 Bil
PE Ratio: 39.19
PB Ratio: 6.92
GF Score: 78/100 
Stryker Corp at Wells Fargo Healthcare Conference Transcript
Sep 08, 2022 / 06:35PM GMT
Release Date Price:
R$57.08
(+8.04%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
All right. Good afternoon, everyone. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. It is my pleasure to host this session with Stryker. With us, we have Glenn Boehnlein, the CFO; and Jason Beach, the Vice President of Investor Relations. In terms of format, it's going to be a fireside chat. If anybody has a question, just raise your hand and we'll call on you. Glenn and Jason, thanks so much for being here.
Glenn S. Boehnlein
Stryker Corporation - VP & CFO
Yes. Thanks for having us.
Jason Beach
Stryker Corporation - VP of IR
Thanks for having us.
Questions & Answers
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
So Glenn, we've been starting all of these fireside chats, almost all, with macro questions, not a surprise. And the market has obviously been
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers